BioCentury
ARTICLE | Clinical News

Medivir preclinical data

April 3, 2006 7:00 AM UTC

Researchers published in Antimicrobial Agents and Chemotherapy that MIV-210, a nucleoside analog prodrug of 3'-fluoro-2', 3'-dideoxyguanosine (FLG), was active against both lamivudine- and adefovir-re...